James Stearns

James Stearns serves as the Chief Investment Officer (International) at China Medical System Holdings Ltd since April 2021 and is actively involved in various capacities across multiple organizations. In addition to their role at China Medical System Holdings Ltd, James holds positions as a Non Executive Director at Neurelis, Inc., Qureight, EYE TECH CARE, and Monkey Puzzle Day Nurseries Ltd, along with a Board Observer role at Acclaro Medical and Acticor Biotech. Furthermore, James has contributed as a Non Executive Director at Destiny Pharma plc and Blueberry Therapeutics Ltd, and participates in the Investment Committee for CMS Ventures.